Floatz logo

Therapeutic Asset Ratings

6,305 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Quemliclustat
Ureter Transitional Cell Carcinoma
Fred Hutchinson Cancer CenterP1/2CC (47)
Quemliclustat
Infiltrating Bladder Urothelial Carcinoma
Fred Hutchinson Cancer CenterP1/2CC (47)
Quemliclustat
Malignant Renal Pelvis Neoplasm
Fred Hutchinson Cancer CenterP1/2CC (47)
Quemliclustat
Ureter Cancer
Fred Hutchinson Cancer CenterP1/2CC (47)
Recombinant Human Egf-Rp64K
Non-Small Cell Squamous Lung Carcinoma
Roswell Park Cancer InstituteP1/2CC (47)
Recombinant Human Granulocyte Colony-Stimulating Factor
Acute Biphenotypic Leukemia
University of WashingtonP1/2CC (47)
Recombinant Human Granulocyte Colony-Stimulating Factor
Hematopoietic And Lymphoid Cell Neoplasm
Fred Hutchinson Cancer CenterP1/2CC (47)
Recombinant Human Granulocyte Colony-Stimulating Factor
Myelodysplastic Syndrome With Excess Blasts
Fred Hutchinson Cancer CenterP1/2CC (47)
Regn15505
Nonpapillary Renal Cell Carcinoma
Regeneron PharmaceuticalsP1/2CC (47)
Regn4336
Nonpapillary Renal Cell Carcinoma
Regeneron PharmaceuticalsP1/2CC (47)
Regv131
Hemophilia B
Regeneron PharmaceuticalsP1/2CC (47)
Relatlimab
Hodgkins Lymphoma
Bristol-Myers SquibbP1/2CC (47)
Retifanlimab
Astrocytoma, IDH-Mutant, Grade 4
Mayo ClinicP1/2CC (47)
Retifanlimab
High Grade B-Cell Lymphoma
University of WashingtonP1/2CC (47)
Rezatapopt
Gallbladder Cancer
PMV Pharmaceuticals, IncP1/2CC (47)
Ribociclib
Invasive Breast Carcinoma
Jonsson Comprehensive Cancer CenterP1/2CC (47)
Rifaximin
Cervical Adenocarcinoma
Mansoura UniversityP1/2CC (47)
Rimiducid
Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP1/2CC (47)
Rintatolimod
Malignant Pancreatic Neoplasm
Joachim Aerts, MD PhDP1/2CC (47)
RM-718
Acquired Hypothalamic Obesity
Rhythm Pharmaceuticals, Inc.P1/2CC (47)
RM-718
Prader-Willi Syndrome
Rhythm Pharmaceuticals, Inc.P1/2CC (47)
rn3161
Obesity Disorder
Ikaria Bioscience Pty LtdP1/2CC (47)
RNK05047
Diffuse Large B-Cell Lymphoma
Ranok Therapeutics (Hangzhou) Co., Ltd.P1/2CC (47)
Rocbrutinib
Follicular Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.P1/2CC (47)
rp-001
Cancer
Recurv Pharma IncP1/2CC (47)
Showing 2576 to 2600 of 6,305 assets
PreviousPage 104 of 253Next